Cargando…

Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)

BACKGROUND: Little information is available on the causes of death among persons with classic Kaposi's sarcoma (CKS). METHODS: We conducted a population-based study in Italy to identify deceased persons with CKS and the underlying causes of death among them, by reviewing multiple-causes-of-deat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascoli, V, Minelli, G, Kanieff, M, Crialesi, R, Frova, L, Conti, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768094/
https://www.ncbi.nlm.nih.gov/pubmed/19707194
http://dx.doi.org/10.1038/sj.bjc.6605265
_version_ 1782173434510311424
author Ascoli, V
Minelli, G
Kanieff, M
Crialesi, R
Frova, L
Conti, S
author_facet Ascoli, V
Minelli, G
Kanieff, M
Crialesi, R
Frova, L
Conti, S
author_sort Ascoli, V
collection PubMed
description BACKGROUND: Little information is available on the causes of death among persons with classic Kaposi's sarcoma (CKS). METHODS: We conducted a population-based study in Italy to identify deceased persons with CKS and the underlying causes of death among them, by reviewing multiple-causes-of-death records. Standardised mortality ratios (SMRs) and 95% confidence intervals were calculated to compare the distribution of causes to that among the same-age general population of deceased persons. The geographical distribution was also evaluated. RESULTS: Of the 946 deaths among persons with CKS, 65.9% were attributable to non-neoplastic conditions and 21.9% to malignancies. For 12.2%, no lethal pathology was identified and CKS was considered as the underlying cause. In 90% of these cases, there was visceral/nodal involvement, therapy-related complications, or neoplastic cachexia. Among persons with CKS who died of other causes, an excess for lymphoid malignancies emerged (SMR=4.40) (chronic lymphocytic leukaemia (11.03), non-Hodgkin's lymphoma (4.22), Hodgkin's lymphoma (11.80), and multiple myeloma (2.3)), balanced by a deficit for all solid cancers (0.56), with a marked deficit for lung cancer (0.41). We found an excess for respiratory diseases (chronic obstructive pulmonary disease (1.86)) and genitourinary diseases (chronic renal failure (6.47)). There was marked geographical heterogeneity in the distribution of deaths. CONCLUSIONS: Though referring specifically to Italy, the results are informative for other countries and populations and all cases of CKS in general.
format Text
id pubmed-2768094
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27680942010-10-06 Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002) Ascoli, V Minelli, G Kanieff, M Crialesi, R Frova, L Conti, S Br J Cancer Clinical Study BACKGROUND: Little information is available on the causes of death among persons with classic Kaposi's sarcoma (CKS). METHODS: We conducted a population-based study in Italy to identify deceased persons with CKS and the underlying causes of death among them, by reviewing multiple-causes-of-death records. Standardised mortality ratios (SMRs) and 95% confidence intervals were calculated to compare the distribution of causes to that among the same-age general population of deceased persons. The geographical distribution was also evaluated. RESULTS: Of the 946 deaths among persons with CKS, 65.9% were attributable to non-neoplastic conditions and 21.9% to malignancies. For 12.2%, no lethal pathology was identified and CKS was considered as the underlying cause. In 90% of these cases, there was visceral/nodal involvement, therapy-related complications, or neoplastic cachexia. Among persons with CKS who died of other causes, an excess for lymphoid malignancies emerged (SMR=4.40) (chronic lymphocytic leukaemia (11.03), non-Hodgkin's lymphoma (4.22), Hodgkin's lymphoma (11.80), and multiple myeloma (2.3)), balanced by a deficit for all solid cancers (0.56), with a marked deficit for lung cancer (0.41). We found an excess for respiratory diseases (chronic obstructive pulmonary disease (1.86)) and genitourinary diseases (chronic renal failure (6.47)). There was marked geographical heterogeneity in the distribution of deaths. CONCLUSIONS: Though referring specifically to Italy, the results are informative for other countries and populations and all cases of CKS in general. Nature Publishing Group 2009-10-06 2009-08-25 /pmc/articles/PMC2768094/ /pubmed/19707194 http://dx.doi.org/10.1038/sj.bjc.6605265 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Ascoli, V
Minelli, G
Kanieff, M
Crialesi, R
Frova, L
Conti, S
Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)
title Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)
title_full Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)
title_fullStr Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)
title_full_unstemmed Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)
title_short Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)
title_sort cause-specific mortality in classic kaposi's sarcoma: a population-based study in italy (1995–2002)
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768094/
https://www.ncbi.nlm.nih.gov/pubmed/19707194
http://dx.doi.org/10.1038/sj.bjc.6605265
work_keys_str_mv AT ascoliv causespecificmortalityinclassickaposissarcomaapopulationbasedstudyinitaly19952002
AT minellig causespecificmortalityinclassickaposissarcomaapopulationbasedstudyinitaly19952002
AT kanieffm causespecificmortalityinclassickaposissarcomaapopulationbasedstudyinitaly19952002
AT crialesir causespecificmortalityinclassickaposissarcomaapopulationbasedstudyinitaly19952002
AT froval causespecificmortalityinclassickaposissarcomaapopulationbasedstudyinitaly19952002
AT contis causespecificmortalityinclassickaposissarcomaapopulationbasedstudyinitaly19952002